TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Cypromed AS
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
27,337
|
25,371
|
24,536 |
Financial expenses |
88
|
40
|
45 |
Earnings before taxes |
4,292
|
4,188
|
4,892 |
Total assets |
17,381
|
14,867
|
13,527 |
Current assets |
16,889
|
14,346
|
12,799 |
Current liabilities |
11,567
|
9,310
|
8,135 |
Equity capital |
5,814
|
5,558
|
5,391 |
- share capital |
373
|
397
|
419 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
33.5%
|
37.4%
|
39.9% |
Turnover per employee | |||
Profit as a percentage of turnover |
15.7%
|
16.5%
|
19.9% |
Return on assets (ROA) |
25.2%
|
28.4%
|
36.5% |
Current ratio |
146.0%
|
154.1%
|
157.3% |
Return on equity (ROE) |
73.8%
|
75.4%
|
90.7% |
Change turnover |
3,525
|
2,124
|
3,319 |
Change turnover % |
15%
|
9%
|
16% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.